Preliminary Report on Radioactive <sup>125</sup>I Seed Implant Brachytherapy for Salivary Malignancy

ZHAO Ke; LUO Hong; WU Ya-dong; HUANG Guang-lei

doi:10.13422/j.cnki.syfjx.2010.14.072

您当前的位置：

首页 >

文章列表页 >

Preliminary Report on Radioactive ¹²⁵I Seed Implant Brachytherapy for Salivary Malignancy

更新时间：2024-09-23

- Preliminary Report on Radioactive ¹²⁵I Seed Implant Brachytherapy for Salivary Malignancy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 14, Pages: 189-191(2010)
- 作者机构：
  
  贵州省人民医院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.14.072
  CLC： R730.5
- Published：2010
- 稿件说明：
移动端阅览
[1]赵科,罗洪,吴亚东,黄光磊.放射性~(125)I粒子组织间植入近距离治疗唾液腺恶性肿瘤的初步报告[J].中国实验方剂学杂志,2010,16(14):189-191.

ZHAO Ke, LUO Hong, WU Ya-dong, et al. Preliminary Report on Radioactive ¹²⁵I Seed Implant Brachytherapy for Salivary Malignancy[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(14): 189-191.
[1]赵科,罗洪,吴亚东,黄光磊.放射性~(125)I粒子组织间植入近距离治疗唾液腺恶性肿瘤的初步报告[J].中国实验方剂学杂志,2010,16(14):189-191. DOI： 10.13422/j.cnki.syfjx.2010.14.072.

ZHAO Ke, LUO Hong, WU Ya-dong, et al. Preliminary Report on Radioactive ¹²⁵I Seed Implant Brachytherapy for Salivary Malignancy[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(14): 189-191. DOI： 10.13422/j.cnki.syfjx.2010.14.072.

摘要

目的:探讨应用放射性125I粒子组织间植入近距离治疗唾液腺恶性肿瘤的疗效。方法:12例唾液腺恶性肿瘤利用放射性125I粒子组织间植入近距离治疗

其中8例采用手术完整切除+粒子植入

2例为手术部分切除+粒子植入

2例因患者无法耐受手术而单纯粒子植入。结果:随访时间2～36个月

单纯粒子植入治疗组肿瘤明显缩小

部分切除+粒子植入组肿瘤完全消失

手术完整切除+粒子植入组至今未复发。以上患者局部控制率91%。结论:放射性125I粒子组织内植入近距离治疗唾液腺恶性肿瘤疗效肯定

但其远期疗效还有待进一步观察随访。

Abstract

Objective:To investgate the efficacy of radioactive 125I seed implant brachytherapy for salivary malignancy.Method:Twelve patients with salivary malignancy were treated by radioactive 125 I seed implanting.Eight patients’tumors were completely resected by surgery.Two patients’tumors were part resected by surgery.Two patients did not accept the surgery because they could not tolerate surgery.Result:All the patients were followed up for 2-36 months.The volume of tumors for those with radioactive therapy and without surgery was reduced obviously.Two patients’tumors were disappeared by partially surgery plus radioactive therapy.Eight patients who accepted complete operations had no local recurrence.The local control rate was 91%.Conclusion:The radioactive 125I seed implant brachytherapy for salivary malignancy is effective.But the long-term effects need further investigation.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Preliminary Report on Radioactive I Seed Implant Brachytherapy for Salivary Malignancy

Related Author

ZHAO Ke

LUO Hong

WU Ya-dong

HUANG Guang-lei

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Preliminary Report on Radioactive 125I Seed Implant Brachytherapy for Salivary Malignancy

DOI：10.13422/j.cnki.syfjx.2010.14.072

摘要

Abstract

关键词

Keywords

references

Preliminary Report on Radioactive ¹²⁵I Seed Implant Brachytherapy for Salivary Malignancy